Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 10, 2015, Pages 1327-1336

  Yang, Peng ^a   Subbaiah, Papasani V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Enzyme inhibition; Hepatic lipase; PC species; Sphingomyelin; Substrate specificity; TAG species

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; SPHINGOMYELIN; VERY LOW DENSITY LIPOPROTEIN; HEPATIC LIPASE, HUMAN; LIPOPROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ARTICLE; CONTROLLED STUDY; DEPLETION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; HYDROLYSIS; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; THIN LAYER CHROMATOGRAPHY; BLOOD; CHEMISTRY; METABOLISM; PHYSIOLOGY;

HUMANS; LIPASE; LIPOPROTEINS; PHOSPHATIDYLCHOLINES; SPHINGOMYELINS; SUBSTRATE SPECIFICITY; TRIGLYCERIDES;

EID: 84937884546     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.07.003     Document Type: Article

References (33)

1. A. Zambon, S. Deeb, P. Pauletto, G. Crepaldi, and J.D. Brunzell Hepatic lipase: a marker for cardiovascular disease risk and response to therapy Curr. Opin. Lipidol. 14 2003 179 189
2. W. Annema, and U. Tietge Role of hepatic lipase and endothelial lipase in high-density lipoprotein mediated reverse cholesterol transport Curr. Atheroscler. Rep. 13 2011 257 265
3. A. Zambon, S. Bertocco, N. Vitturi, V. Polentarutti, D. Vianello, and G. Crepaldi Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins Biochem. Soc. Trans. 31 2003 1070 1074
4. C. Ehnholm, and T. Kuusi Preparation, characterization, and measurement of hepatic lipase Methods Enzymol. 129 1986 716 738
5. T.D. Watson, M.J. Caslake, D.J. Freeman, B.A. Griffin, J. Hinnie, C.J. Packard, and J. Shepherd Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects Arterioscler. Thromb. Vasc. Biol. 14 1994 902 910
6. M. Kawakami, T. Murase, H. Itakura, N. Yamada, N. Ohsawa, and F. Takaku Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity Microbiol. Immunol. 30 1986 849 854
7. L.E. Rufibach, S.A. Duncan, M. Battle, and S.S. Deeb Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter J. Lipid Res. 47 2006 1463 1477
8. B. Chellan, E.P. Koroleva, T.J. Sontag, A.V. Tumanov, Y.X. Fu, G.S. Getz, and C.A. Reardon LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells PLoS One 8 2013 e54719
9. P.V. Subbaiah, and M. Liu Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase J. Biol. Chem. 268 1993 20156 20163
10. L. Gesquiere, W. Cho, and P.V. Subbaiah Role of group IIa and group V secretory phospholipases A2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin Biochemistry 41 2002 4911 4920
11. D.K. Singh, and P.V. Subbaiah Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids J. Lipid Res. 48 2007 683 692
12. P. Yang, N.A. Belikova, J. Billheimer, D.J. Rader, J.S. Hill, and P.V. Subbaiah Inhibition of endothelial lipase activity by sphingomyelin in the lipoproteins Lipids 49 2014 987 996
13. J.S. Hill, R.C. Davis, D. Yang, M.C. Schotz, and H. Wong Hepatic lipase: high-level expression and subunit structure determination E.A.D. Byron Rubin, Methods in Enzymology Lipases, Part A: Biotechnology 1997 Academic Press 232 246
14. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
15. J.A. Glomset The plasma lecithin:cholesterol acyltransferase reaction J. Lipid Res. 9 1968 155 167
16. K. Shirai, R.L. Barnhart, and R.L. Jackson Hydrolysis of human plasma high density lipoprotein 2 phospholipids and triglycerides by hepatic lipase Biochem. Biophys. Res. Commun. 29 1981 591 599
17. D.J. Bolin, and A. Jonas Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding J. Biol. Chem. 271 1996 19152 19158
18. M.F. Tong, and A. Kuksis Effect of different neutral phospholipids on apolipoprotein binding by artificial lipid particles in vivo Biochem. Cell Biol. 64 1986 826 835
19. I. Arimoto, H. Saito, Y. Kawashima, K. Miyajima, and T. Handa Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions J. Lipid Res. 39 1998 143 151
20. J.W. Jones, and P. Ways Abnormalities of high density lipoproteins in abetalipoproteinemia J. Clin. Invest. 46 1967 1151 1161
21. P.N. Herbert, J.S. Hyams, D.N. Bernier, M.M. Berman, A.L. Saritelli, K.M. Lynch, A.V. Nichols, and T.M. Forte Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis J. Clin. Invest. 76 1985 403 412
22. T.S. Jeong, S.L. Schissel, I. Tabas, H.J. Pownall, A.R. Tall, and X.C. Jiang Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase J. Clin. Invest. 101 1998 905 912
23. A. Yamamoto, K. Ishikawa, S. Uhara, S. Adachi, and M. Nishikawa Relationship between serum lipid components in hyperlipemia J. Biochem. 74 1973 59 65
24. G. Stubiger, E. Aldover-Macasaet, W. Bicker, G. Sobal, A. Willfort-Ehringer, K. Pock, V. Bochkov, K. Widhalm, and O. Belgacem Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS Atherosclerosis 224 2012 177 186
25. D.R. Illingworth, S.S. Alam, and N.A. Alam Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia Metabolism 32 1983 869 873
26. T.R. Gamlen, and D.P.R. Muller The validation and use of specific methods for the estimation of lipoprotein lipase and hepatic lipase activities in post-heparin plasma of children with hyperlipidaemia Clin. Chim. Acta 106 1980 75 83
27. T. Murase, T. Ebara, and M. Okubo Hepatic lipase activity is decreased in Japanese patients with type III hyperlipoproteinemia Clin. Chim. Acta 414 2012 185 187
28. X.C. Jiang, F. Paultre, T.A. Pearson, R.G. Reed, C.K. Francis, M. Lin, L. Berglund, and A.R. Tall Plasma sphingomyelin level as a risk factor for coronary artery disease Arterioscler. Thromb. Vasc. Biol. 20 2000 2614 2618
29. T.S. Park, R.L. Panek, S.B. Mueller, J.C. Hanselman, W.S. Rosebury, A.W. Robertson, E.K. Kindt, R. Homan, S.K. Karathanasis, and M.D. Rekhter Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice Circulation 110 2004 3465 3471
30. J.C. Nelson, X.C. Jiang, I. Tabas, A. Tall, and S. Shea Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis Am. J. Epidemiol. 163 2006 903 912
31. J. Yeboah, C. McNamara, X.C. Jiang, I. Tabas, D.M. Herrington, G.L. Burke, and S. Shea Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: multi-ethnic study of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 30 2010 628 633
32. M. Duong, M. Psaltis, D.J. Rader, D. Marchadier, P.J. Barter, and K.A. Rye Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids Biochemistry 42 2003 13778 13785
33. Y. Yang, T. Kuwano, W.R. Lagor, C.J. Albert, S. Brenton, D.J. Rader, D.A. Ford, and R.J. Brown Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species Lipids 49 2014 505 515